• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Global Protein Therapeutics Market Outlook 2018 - Product Image

Global Protein Therapeutics Market Outlook 2018

  • ID: 2729030
  • January 2014
  • Region: Global
  • 140 Pages
  • RNCOS E-Services Private Limited

FEATURED COMPANIES

  • Abbott Laboratories
  • Amgen Inc.
  • Biogen Idec Inc.
  • Eli Lilly & Company
  • Johnson & Johnson
  • Merck Serono S.A.
  • MORE

Protein based therapies have found a prominent place in the biopharmaceutical industry since the launch of the human insulin product. They have become one of the most effective clinical methods to treat a wide spectrum of diseases ranging from cancer to metabolic disorders. The market holds tremendous potential for future growth and it is estimated that by the end of 2018, it may reach the mark of US$ 165 Billion as new products (especially monoclonal antibodies in the advanced clinical phase) may enter the sector.

According to this new research report, “Global Protein Therapeutics Market Outlook 2018”, a large number of market players has been developing monoclonal antibodies (mAbs). This research has found that mAbs contribute the largest shares in the number of protein therapeutic products under pipeline. The report, in this context, gives a comprehensive analysis of the current and future patterns of revenue generation with respect to mAbs and other segments.

Through in-depth and prudent analysis of the developments taking place at the global level, the authors have observed that the US holds a dominant position in the global protein therapeutics market READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Amgen Inc.
  • Biogen Idec Inc.
  • Eli Lilly & Company
  • Johnson & Johnson
  • Merck Serono S.A.
  • MORE

1. Analyst View

2. Research Methodology

3. Global Protein Therapeutics Market
3.1 Protein Therapeutics Market vs Pharmaceutical Market
3.2 Current and Future Market Analysis to 2018
3.2.1 Market Segmentation

4. Industry Performance
4.1 Monoclonal Antibodies (mAbs)
4.1.1 Scientific Insight
4.1.2 Current and Future Market Analysis to 2018
4.1.3 By Application
4.1.4 Key Geographical Markets
4.1.5 Key Players and Drugs
4.1.6 Recent Developments
4.2 Erythropoietin (EPO)
4.2.1 Scientific Insight
4.2.2 Current and Future Market Analysis to 2018
4.2.3 By Application
4.2.4 Key Geographical Markets
4.2.5 Key Players and Drugs
4.2.6 Recent Developments
4.3 Insulin
4.3.1 Scientific Insight
4.3.2 Current and Future Market Analysis to 2018
4.3.3 By Application
4.3.4 Key Geographical Markets
4.3.5 Key Players and Drugs
4.3.6 Recent Developments
4.4 Interferon (IFN)
4.4.1 Scientific Insight
4.4.2 Current and Future Market Analysis to 2018
4.4.3 By Application
4.4.4 Key Geographical Markets
4.4.5 Key Players and Drugs
4.4.6 Recent Developments
4.5 Human Growth Hormone (HGH)
4.5.1 Scientific Insight
4.5.2 Current and Future Market Analysis to 2018
4.5.3 Key Geographical Markets
4.5.4 Key Players and Drugs
4.5.5 Recent Developments
4.6 Blood Clotting Factor
4.6.1 Scientific Insight
4.6.2 Current and Future Market Analysis to 2018
4.6.3 Key Players and Drugs
4.6.4 Recent Developments
4.7 Follicle Stimulating Hormone (FSH)
4.7.1 Scientific Insight
4.7.2 Current and Future Market Analysis to 2018
4.7.3 Key Players and Drugs
4.7.4 Recent Developments
4.8 Granulocyte Colony Stimulating Factor (G-CSF)
4.8.1 Scientific Insight
4.8.2 Current and Future Market Analysis to 2018
4.8.3 Key Players and Drugs
4.8.4 Recent Developments

5. Advanced Phase Drugs Analysis

6. Emerging Market Trends
6.1 Gaining Momentum: Strategic Activities among Players to Develop Novel Treatments
6.2 Effective Delivery Methods: Improving the Reach of Therapies
6.3 Players Investing Heavily in Multiple Sclerosis and Cancer Therapeutics

7. Key Players
7.1 Johnson & Johnson
7.2 Biogen Idec Inc.
7.3 Eli Lilly & Company
7.4 Sanofi-Aventis
7.5 Merck Serono S.A.
7.6 Roche Group
7.7 Amgen Inc.
7.8 Pfizer
7.9 Abbott Laboratories
7.10 Novo Nordisk

List of Tables

Table 4-1: Global - Key Players and Drugs in Monoclonal Antibody Market (Billion US$), 2010-2012
Table 4-2: US - Sales of Key EPO Products (Billion US$), 2010-2012
Table 4-3: Global - Key Players and Drugs in Erythropoietin Alfa Market (Billion US$), 2010-2012
Table 4-4: Global - Key Players and Drugs in Erythropoietin Beta Market (Billion US$), 2010-2012
Table 4-5: Global - Key Players and Drugs in Darbepoetin Market (Billion US$), 2010-2012
Table 4-6: China - Diabetic Patients in Age Group 20-79 Years ('000), 2012 & 2030f
Table 4-7: US - Diabetic Patients in Age Group 20-79 Years ('000), 2012 & 2030f
Table 4-8: Japan - Diabetic Patients in Age Group 20-79 Years ('000), 2012 & 2030
Table 4-9: Global - Key Players and Drugs in Interferon Alpha Market (Billion US$), 2010-2012
Table 4-10: Global - Key Players and Drugs in Interferon Beta Market (Billion US$), 2010-2012
Table 4-11: Global - Key Players and Drugs in Human Growth Hormone Market (Billion US$), 2010-2012
Table 4-12: Global - Key Players and Drugs in Blood Clotting Factor Market (Billion US$), 2010-2012
Table 4-13: Global - Key Players and Drugs in Follicle Stimulating Hormone Market (Billion US$), 2010-2012
Table 4-14: Global - Key Players and Drugs in Granulocyte Colony Stimulating Factor Market (Billion US$), 2010-2012
Table 5-1: Advanced Phase Protein Therapeutics
Table 7-1: Johnson & Johnson - Key Products in Protein Therapeutics
Table 7-2: Biogen Idec - Key Products in Protein Therapeutics
Table 7-3: Eli Lilly - Key Products in Protein Therapeutics
Table 7-4: Sanofi-Aventis - Key Products in Protein Therapeutics
Table 7-5: Merck Serono - Key Products in Protein Therapeutics
Table 7-6: Roche - Key Products in Protein Therapeutics
Table 7-7: Amgen Inc. - Key Products in Protein Therapeutics
Table 7-8: Pfizer Inc. - Key Products in Protein Therapeutics
Table 7-9: Abbott Laboratories - Key Products in Protein Therapeutics
Table 7-10: Novo Nordisk - Key Products in Protein Therapeutics

List of Charts

Figure 3-1: Global - Protein Therapeutics vs Pharmaceutical Market (Billion US$), 2012
Figure 3-2: Global - Protein Therapeutics Market (Billion US$), 2012-2018
Figure 3-3: Global - Protein Therapeutics Market by Segment (%), 2012
Figure 3-4: Global - Forecast for Protein Therapeutics Market by Segment (%), 2018
Figure 4-1: Global - Monoclonal Antibodies Market (Billion US$), 2012-2018
Figure 4-2: Global - Monoclonal Antibodies Market by Application (%), 2012
Figure 4-3: Global - Use of Monoclonal Antibodies in Cancer Treatment (Billion US$), 2011 & 2012
Figure 4-4: Global - Use of Monoclonal Antibodies in Rheumatoid Arthritis Treatment (Billion US$), 2011 & 2012
Figure 4-5: Global - Use of Monoclonal Antibodies in Other Chronic Diseases Treatment (Billion US$), 2011 & 2012
Figure 4-6: US - Monoclonal Antibodies Market (Billion US$), 2012-2018
Figure 4-7: Europe - Monoclonal Antibodies Market (Billion US$), 2012-2018
Figure 4-8: Japan - Monoclonal Antibodies Market (Billion US$), 2012-2018
Figure 4-9: Global - Erythropoietin Market (Billion US$), 2012-2018
Figure 4-10: Global - Number of Patients on Dialysis (Million), 2010-2012
Figure 4-11: Global - Breakup of Patients on Dialysis by Region (%), 2012
Figure 4-12: Global - Number of New Cancer Cases (Million), 2009 & 2020
Figure 4-13: Global - Breakup of New Cancer Cases by Region (%), 2009
Figure 4-14: Global - Share of US in EPO Market (2012)
Figure 4-15: Global - Insulin Market (Billion US$), 2012-2018
Figure 4-16: Global - Number of Diabetic Patients (Million), 2012 & 2030
Figure 4-17: China - Insulin Market (Billion US$), 2012-2018
Figure 4-18: US - Insulin Market (Billion US$), 2012-2018
Figure 4-19: Japan - Insulin Market (Billion US$), 2012-2018
Figure 4-20: Global - Share of Key Players in Insulin Market (2012)
Figure 4-21: Global - Share of Products in Insulin Market (2012)
Figure 4-22: Global - Interferon Market (Billion US$), 2012-2018
Figure 4-23: Global - Share of Alpha and Beta Products in Interferon Market (2012)
Figure 4-24: Global - Interferon Alpha Market (Billion US$), 2010-2012
Figure 4-25: Global - Interferon Beta Market (Billion US$), 2010-2012
Figure 4-26: US - Interferon Market (Billion US$), 2010-2012
Figure 4-27: Japan - Interferon Market (Million US$), 2010-2012
Figure 4-28: Global - Human Growth Hormone Market (Billion US$), 2012-2018
Figure 4-29: Global - Share of Key Players in Human Growth Hormone Market (2012)
Figure 4-30: Global - Blood Clotting Factor Market (Billion US$), 2012-2018
Figure 4-31: Global - Share of Blood Clotting Factor Market by Segment (2012)
Figure 4-32: Global - Share of Key Players in Blood Clotting Factor Market (2012)
Figure 4-33: Global - Follicle Stimulating Hormone Market (Billion US$), 2012-2018
Figure 4-34: Global - Granulocyte Colony Stimulating Factor Market (Billion US$), 2012-2018

Note: Product cover images may vary from those shown

- Abbott Laboratories
- Amgen Inc.
- Biogen Idec Inc.
- Eli Lilly & Company
- Johnson & Johnson
- Merck Serono S.A.
- Novo Nordisk
- Pfizer
- Roche Group
- Sanofi-Aventis

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos